Union Square Park Capital Management, LLC Chembio Diagnostics, Inc. Transaction History

Union Square Park Capital Management, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$2.88 - $5.64 $216,000 - $423,000	-75,000 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.4 - $7.97 $1.11 Million - $2.59 Million	-325,000 Reduced 81.25%	75,000 $263,000
Q4 2020 Feb 12, 2021	BUY	$4.11 - $7.51 $1.64 Million - $3 Million	400,000 New	400,000 $1.9 Million

Ticker CEMI
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,224,600
Description
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...

Get notified when there are updates to the investment portfolio of Union Square Park Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Union Square Park Capital Management, LLC with notifications on news.